Skip to content
Clinical Trials – home
BelgiumBack to Belgium

Clinical trials in Haine-Saint-Paul – page 14

1 436 clinical trials in Haine-Saint-Paul, Belgium. Every trial is listed in the EU Clinical Trials Register and updated daily.

Haine-Saint-Paul at a glance
1 436
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

1 436 trials in Haine-Saint-Paul

Open in trial search

Frexalimab versus Tacrolimus for Prevention of Kidney Transplant Rejection in Adult Kidney Transplant Recipients

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Frexalimab
  • Sponsor:Sanofi-Aventis Recherche & Developpement

A study to evaluate the efficacy and safety of DYNE-101 in patients with Myotonic Dystrophy Type 1

Registered drug
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years
  • Substances:Potassium Chloride
  • Sponsor:Dyne Therapeutics Inc.

A study to evaluate the safety and effectiveness of IKT-001 compared to a placebo in adults with pulmonary arterial hypertension.

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:IKT-001PRO
  • Sponsor:Inhibikase Therapeutics Inc.

A study on the effectiveness of cagrilintide and semaglutide for weight management in children and adolescents with obesity

Investigational
Countries:BelgiumBelgium
  • Participants:0–17 years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S

Ovarian cancer

Recruiting

A study of sacituzumab tirumotecan and bevacizumab in patients with newly diagnosed advanced ovarian cancer following first-line platinum-based chemotherapy

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Merck Sharp & Dohme LLC

Homocystinuria

Recruiting

A study to evaluate the safety and effectiveness of pegtibatinase in patients aged 12 to 65 years with classical homocystinuria.

Investigational
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Pegtibatinase
  • Sponsor:Travere Therapeutics Inc.

Obesity+1

Recruiting

A study of eloralintide in adults with persistent obesity or overweight who are currently treated with a weekly incretin medication

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:LY3841136 sodium
  • Sponsor:Eli Lilly & Co.

Bladder cancer

Recruiting

A study of sacituzumab tirumotecan versus docetaxel, paclitaxel, or vinflunine for patients with pretreated advanced or metastatic bladder cancer

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Docetaxel
  • Sponsor:Merck Sharp & Dohme LLC

Rett syndrome

Recruiting

A Phase 3 Study of Fenfluramine Hydrochloride for Safety and Efficacy in Patients with Rett Syndrome

Registered drug
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years
  • Substances:Fenfluramine Hydrochloride
  • Sponsor:UCB Biosciences Inc.

Breast cancer+1

Recruiting

Maintenance Therapy Study of Inavolisib with Pertuzumab and Trastuzumab in Patients with HER2‑Positive, PIK3CA‑Mutated Locally Advanced or Metastatic Breast Cancer

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:F. Hoffmann-La Roche AG

Evaluating measles, mumps, rubella vaccine (live) in lactating women to enhance infant mucosal immunity

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years · Healthy volunteers
  • Substances:Measles Virus Edmonston-Enders Strain (Live, Attenuated) Produced In Chick Embryo Cells
  • Sponsor:Universite Libre de Bruxelles

Phase 2 Study of Rinatabart Sesutecan with Pegfilgrastim in Adults with Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Glatiramer Acetate
  • Sponsor:Genmab A/S

Other cities in Belgium

The busiest research cities in the country

All 164 cities in Belgium

Clinical research in Haine-Saint-Paul

What the registry says about research in the country

01 Hematologic Oncology

Innovative research focusing on chronic lymphocytic leukemia treatment combinations, evaluating the effectiveness of targeted therapies using ibrutinib and venetoclax. The trials aim to determine optimal treatment duration and progression-free survival outcomes.

  • Treatment Response Assessment
  • Therapy Optimization
  • Disease Monitoring

Advanced studies are exploring personalized treatment approaches for patients with various response patterns.

02 Breast Cancer Research

Clinical investigations examining treatment strategies for elderly patients with HER2-negative breast cancer, specifically focusing on the combination of chemotherapy and hormone therapy based on genomic profiling.

  • Genomic Grade Assessment
  • Age-Specific Treatment
  • Survival Outcomes

These studies aim to optimize treatment selection for older patients while considering their specific health needs.

03 Advanced Blood Disorders

Comprehensive research on acute myeloid leukemia and myelodysplastic syndrome, investigating the efficacy of combining midostaurin with decitabine in high-risk patients.

  • Treatment Tolerability
  • Response Rates
  • High-Risk Patient Care

The trials focus on developing more effective treatments for patients who may not be eligible for standard intensive therapies.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.